TX-SES
5.11.2014 19:08:04 CET | Business Wire | Pressemeddelelse
With North American oil and gas production on the rise, global satellite operator SES (NYSE Paris:SESG) (LuxX:SESG) today announced it has signed a new capacity agreement with Global Data Systems (GDS) to enable Stallion Oilfield Services to connect an increasing number of oil and gas drilling sites across the US and Canada.
Stallion, a leading provider of integrated wellsite services across North America, has doubled its use of SES satellite bandwidth and intensified its need for GDS full-scale teleport and infrastructure solutions to help the oil and gas industry boost operational efficiencies and workforce welfare.
By growing its service to 72 MHz of Ku-band capacity on SES’s AMC-9 satellite, Stallion is enabling oil and gas companies and drilling contractors to remotely monitor drilling operations from a central site. Stallion is also delivering via satellite a wide range of applications, including high-speed broadband, corporate VPN and MPLS solutions, Netflix, and Skype, to enable drilling crews to remain connected with colleagues, friends and family while working in remote wellsite locations across the country and offshore in the Gulf of Mexico.
“Reliable satellite bandwidth plays a critical role in our ability to help oil and gas operators and drilling rig contractors reduce costs and streamline their operations,” explained Pedro Buhigas, Chief Information Officer for Stallion. “Exploration and production firms are increasingly relying on communications infrastructure to bring real-time information to their central office locations,” Buhigas said, citing a recent industry trend. “On the other end of the spectrum, satellite-delivered applications as simple as a phone call and internet access are ensuring that wellsite crews from the Gulf of Mexico to Alaska remain connected with their family and friends facilitating a higher quality of life while away from home. Being able to provide these services results in added value to our customers and enables them to stay well focused.”
“Our partnership with GDS and Stallion represents a real growth story for SES in North America,” stated John Matlaga, Vice President of Enterprise and Mobility Services for SES in North America. “This expansion further highlights the high-powered AMC-9 satellite as an ideal option for supporting oil and gas operations across the Gulf of Mexico and throughout the region.”
“Stallion is providing comprehensive accommodations support to every phase of North America’s remote oil and gas operations – from exploration to production, and GDS is customizing the network solutions needed to meet the daily requirements in the oil and gas market,” said Ned Fasullo, Chief Marketing Officer for Global Data Systems. “We look forward to working with SES and Stallion to turn some of the most remote locations in North America into the most connected operations in the world.”
Follow us on:
Twitter: https://twitter.com/SES_Satellites
LinkedIn: http://www.linkedin.com/company/ses
Facebook: https://www.facebook.com/SES.YourSatelliteCompany
YouTube: http://www.youtube.com/SESVideoChannel
Blog: http://www.ses.com/blog
SES Pictures are available under: http://www.ses.com/4245221/library
About GDS
Global Data Systems owns and operates a commercial satellite teleport connected to a modular datacenter on company owned property at the junction of Interstate 10 and Interstate 49 in Lafayette, Louisiana. The company, founded in 1987, provides telecommunications, datacenter, systems integration, physical security, and managed services to the Energy, Healthcare, Education, Government and Commercial sectors. Visit GDS online at www.getgds.com .
About Stallion
Stallion Oilfield Services is one of the largest integrated providers of onshore workforce accommodations and related wellsite services to the oil and natural gas industry in the United States. Our service offerings are designed to improve living and working conditions at the wellsite, wellsite safety and the efficiency of our customers’ drilling and production operations. We provide services to a diverse group of customers, ranging in scale from small oilfield service companies to large integrated exploration and production companies. To learn more, visit www.stallionoilfield.com .
About SES
SES is a world-leading satellite operator with a fleet of over 50 geostationary satellites. The company provides satellite communications services to broadcasters, content and internet service providers, mobile and fixed network operators and business and governmental organizations worldwide.
SES stands for long-lasting business relationships, high-quality service and excellence in the broadcasting industry. The culturally diverse regional teams of SES are located around the globe and work closely with customers to meet their specific satellite bandwidth and service requirements.
SES (NYSE Paris:SESG) (LuxX:SESG) holds participations in Ciel in Canada and QuetzSat in Mexico, as well as a strategic participation in satellite infrastructure start-up O3b Networks. Further information under: www.ses.com .
Contact:
SES Communications
Markus Payer
Tel: +352 710 725 500
Markus.Payer@ses.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum